MyHealthChecked Shares Rise as Boots Agrees to Stock Coronavirus Test Kits

By Matteo Castia

Shares in MyHealthChecked PLC rose Tuesday after the healthcare company said it has entered into an agreement with pharmacy group Boots U.K. to launch a home-testing nasal swab test and PCR laboratory testing service to detect the coronavirus.

The company said the kit allows customers to take a nasal swab themselves at home and send samples by post to laboratories.

The tests will be available at Boots' stores and online and be processed at a laboratory run by MyHealthChecked and molecular diagnostics supplier Yourgene Health PLC, the company said. Results are then provided within 24 to 48 hours via an online portal, it said.

The deal has an initial term of 12 months and a one-month notice period for termination thereafter.

Boots is owned by drug-store chain Walgreens Boots Alliance Inc.

Meanwhile, MyHealthChecked entered into an agreement with Yourgene to act as the company's exclusive external provider of testing services.

The deal isn't for a fixed period but is subject to a six-month notice clause, and entails a minimum testing volume of 200 tests a week and 800 tests a calendar month for the first three months, the company said.

MyHealthChecked shares at 1305 GMT were up 1.65 pence, or 34%, at 6.45 pence.

Write to Matteo Castia at [e-mail]

(END) Dow Jones Newswires

April 06, 2021 09:29 ET (13:29 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.